Late-Stage Diversification of Imidazole-Based Pharmaceuticals through Pd-Catalyzed Regioselective C-H Bond Arylations - Université de Rennes Accéder directement au contenu
Article Dans Une Revue Journal of Organic Chemistry Année : 2019

Late-Stage Diversification of Imidazole-Based Pharmaceuticals through Pd-Catalyzed Regioselective C-H Bond Arylations

Résumé

Palladium-catalyzed C-H bond arylation of imidazoles has been applied to pharmaceuticals such as Bifonazole, Climbazole, and Prochloraz. In the presence of phosphine-free Pd(OAc)(2) catalyst, aryl bromides are efficiently coupled at the CS-position of the imidazole units, which are widely decorated. Under these conditions, only C-H bond arylation reaction occurred without affecting the integrity of chemical structure of the imidazole-based pharmaceuticals. Moreover, with Bifonazole Pd-catalyzed C-H bond diarylation at the C2- and C5-positions of imidazole unit has also been performed.
Fichier principal
Vignette du fichier
Soule_et al_2019_Late-Stage Diversification of Imidazole-Based Pharmaceuticals_accepted.pdf (2 Mo) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)
Loading...

Dates et versions

hal-02359968 , version 1 (26-11-2019)

Identifiants

Citer

Amal Benzai, Xinzhe Shi, Fazia Derridj, Thierry Roisnel, Henri Doucet, et al.. Late-Stage Diversification of Imidazole-Based Pharmaceuticals through Pd-Catalyzed Regioselective C-H Bond Arylations. Journal of Organic Chemistry, 2019, 84 (20), pp.13135-13143. ⟨10.1021/acs.joc.9b01469⟩. ⟨hal-02359968⟩
65 Consultations
268 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More